Abstract: INTRODUCTION:: Early prediction of massive transfusion (MT) is critical in the management of severely injured trauma patients. Variables available early after injury including physiologic, laboratory, and rotation thromboelastometric (ROTEM) parameters were evaluated as predictors for the need of MT. METHODS:: After Institutional Review Board approval, we retrospectively reviewed a cohort of severely injured trauma patients (Injury Severity Score 16) admitted to a Level I trauma center with available ROTEM measurements on hospital admission during a 1-year study period. Patients with isolated head injury (Abbreviated Injury Scale head 3 and Abbreviated Injury Scale chest, abdomen, and extremity <3) and patients with a penetrating mechanism of injury were excluded. Patients who received a MT (10 units packed red blood cell within 24 hours of admission) were compared with patients who did not. Variables independently associated with MT were identified using stepwise logistic regression. RESULTS:: A total of 53 patients met inclusion criteria. Of these, 18 patients (34.0%) received a MT and 35 patients (66.0%) did not. Massively transfused patients had significantly lower baseline hemoglobin values (7.9 g/dL ± 0.4 g/dL vs. 11.4 g/dL ± 0.4 g/dL; p < 0.001) and a trend toward higher lactate (4.8 mmol/L ± 0.8 mmol/L vs. 3.0 mmol/L ± 0.3 mmol/L; p = 0.056) and base deficit values (5.9 mmol/L ± 1.1 mmol/L vs. 3.6 mmol/L ± 0.6 mmol/L; p = 0.052). Mean international normalized ratio (1.46 ± 0.07 vs. 1.22 ± 0.05; p = 0.001) and partial thromboplastin times (42.4 seconds ± 5.0 seconds vs. 29.7 seconds ± 1.8 seconds; p < 0.001) were significantly higher in MT patients. Patients receiving a MT had significantly altered ROTEM values on admission compared with non-MT patients. An increase in the clot formation time (471.3 seconds ± 169.9 seconds vs. 178.1 seconds ± 19.9 seconds; p = 0.001), a shortening of the maximum clot firmness (37.5 mm ± 2.9 mm vs. 50.7 mm ± 1.4 mm; p < 0.001), and a shortening of the clot amplitude at all time points (10/20/30 minutes) were observed in massively transfused trauma patients. Variables independently associated with MT included a hemoglobin level 10 g/dL and an abnormal maximum clot firmness value (area under the receiver operator characteristic curve: 0.831 [95% confidence interval: 0.719-0.942; p < 0.001]). CONCLUSION:: Hemoglobin 10 g/dL and an abnormal maximum cloth firmness measured by rotation thromboelastometry on admission reliably predict the need for MT. Prospective validation of the effectiveness of thromboelastometry to guide the transfusion practice after trauma is warranted. 
INTRODUCTION
MassiveTraumatic hemorrhage following injury results in coagulopathy, which subsequently leads to further blood loss. Several mechanisms including tissue injury, hemodilution, hypothermia, acidosis, and inflammation are postulated to be the main causes ofpredispose for traumatic coagulopathy. [1] [2] [3] A recent report by Brohi and colleagues 4 , however, suggested an alternative coagulopathy pathway following major trauma independent of clotting-factor deficiency. Early traumatic coagulopathy occurred exclusively in the setting of tissue hypoperfusion resulting in activation of the thrombomodulin-protein C system, higher tPA levels, and fibrinolysis. While further investigations to fully comprehend pathways of acute coagulopathy are warranted, coagulation abnormalities have been demonstrated to be associated with poor outcomes. 1, 5, 6 Additionally, it has been observed that coagulopathy occurring in the early posttraumatic phase correlates closely with massive transfusion (MT) requirement. 1, 5, 7 After increasing number of studies demonstrating improved outcomes pertinent due to agressive plasma and platelet replacements in patients requiring MT [8] [9] [10] Survival to discharge was 61% in the MT group and 66% in the non-MT group Table 2 . (Table 4) . A significant increase in the CFT, a shortening of the MCF and a shortening of the clot amplitude at all time-points (A10, A20, A30) were observed in massively transfused trauma patients (Table 4 ).
Bivariate analysis was performed to identify risk factors associated with the need for MT (Figure 1 ). The results of the stepwise logistic regression analysis are presented in reported the effect a reduction ofon mortality usingof point-of-care guided transfusion therapy in massively bleeding patients, 21% of those being trauma patients. In this examination, Ppatients treated according to the TEG ® results had a significantly lower
30-day mortality as compared to controls (20% vs. 32%).
While the beneficial value of point-of-care devices to tailor blood component requirements therapyduring transfusion therapy has been previously shown, the goal of the present study was to examine the role of ROTEM ® in the very early prediction of MT in trauma patientsfollowing trauma. One of the earliest attempts to evaluate the usefulness of point-of-care assays in the assessment of the coagulation status in trauma victims was performed conducted by Kaufmann et al. in 1997. 22 In their study, including 69 blunt trauma patients, 65% demonstrated hypercoagulability upon hospital arrival whereas only 10% were hypocoagulable. Of the hypocoagulable patients, 86% received blood products within the first 24 hours, whereas only 4% of the hypercoagulable patients, and none of the patients with completely normal TEG ® parameters required transfusion within the first 24 hours. A hypocoagulable TEG ® was associated with increased ISS and only ISS and TEG ® were predictive of transfusion requirements within the first 24 hours. NeverthelessHowever, the vast majority of patients in that study did not receive a MT. In patients sustaining penetrating insults, Plotkin et al. 23 demonstrated that the maximum clot amplitude significantly correlated with the total amount of blood products used within the initial 24 hours. Conventional coagulation variables, such as INR, prothrombin time and partial thromboplastin time, discriminated hypo-from normo-/hypercoagulopathic patients, but did not predict transfusion requirements. Likewise, in
Martini's swine model 34 , TEG ® appeared to be better superior in detecting mechanisms associated with coagulopathy induced by hypothermia and hemorrhage than conventional coagulation markers.
In the present examination, we evaluated several physiologic, laboratory as well severely injured patients at the discretion of the attending physician, and may therefore have resulted in a selection bias. Data on fibrinolysis, guiding transfusion practice in both ROTEM 36 and TEG studies 24 , was not available for the current analysis. Lastly, our study conclusions are limited by the small sample size and the wide variety of injury patterns included. Almost two thirds of our study cohort suffered severe head injuries, a patient population in particularly prone to be at high risk for developing coagulopathy, however, pathways of coagulation abnormalities in head injured patients are likely to be very different to those of suffering torso trauma.
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CONCLUSION
Hemoglobin ≤ 10 g/dL and an abnormal maximum cloth firmness measured by rotation thromboelastometry on admission reliably predict the need for massive transfusion. Further pProspective studies to validatevalidation of the effectiveness of thromboelastometry to guide the transfusion management practice in trauma patientsfollowing trauma isare warranted. 
